Racial and Ethnic Differences in the Risk of Second Primary Melanoma.
No abstract available
CommentIn
doi: 10.1001/jamadermatol.2024.3551
References:
Bradford PT, Freedman DM, Goldstein AM, Tucker MA. Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol. 2010;146(3):265-272. doi:10.1001/archdermatol.2010.2
Schechtman E. Odds ratio, relative risk, absolute risk reduction, and the number needed to treat—which of these should we use? Value Health. 2002;5(5):431-436. doi:10.1046/J.1524-4733.2002.55150.x
Beroukhim K, Pourang A, Eisen DB. Risk of second primary cutaneous and noncutaneous melanoma after cutaneous melanoma diagnosis: a population-based study. J Am Acad Dermatol. 2020;82(3):683-689. doi:10.1016/j.jaad.2019.10.024
Kurtansky NR, Manci RN, Bello DM, et al. . Risk of nonacral cutaneous melanoma after the diagnosis of acral melanoma. Br J Dermatol. 2022;187(3):430-432. doi:10.1111/bjd.21251
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-1457. doi:10.1016/S0140-6736(07)61602-X